Announcement #Lansoprazole for injection of Haichen Pharmaceutical products passed the generic drug consistency evaluation

Shanghai Securities News China Securities Network News (reporter Luo Min) Haichen Pharmaceutical announced that the company recently received the State Drug Administration approved and issued the company's product Lansoprazole for injection "Drug Supplement Application Approval Notice", the product passed the generic drug quality and efficacy consistency evaluation. Lansoprazole for injection can be used in the treatment of diseases such as duodenal ulcer with bleeding, gastric ulcer with bleeding, acute stress ulcer, and acute gastric mucosal lesions that are not suitable for oral therapy.